Department of Anesthesiology, The Second Affiliated Hospital of Harbin Medical University, 246 Xuefu Road, Harbin, 150001, PR China; Heilongjiang Province Key Laboratory of Research on Anesthesiology and Critical Care Medicine, 246 Xuefu Road, Harbin, 150001, PR China; The Key Laboratory of Myocardial Ischemia, Ministry of Education, Heilongjiang Province, 246 Xuefu Road, Harbin, 150001, PR China.
Department of Anesthesiology, The Second Affiliated Hospital of Harbin Medical University, 246 Xuefu Road, Harbin, 150001, PR China; Heilongjiang Province Key Laboratory of Research on Anesthesiology and Critical Care Medicine, 246 Xuefu Road, Harbin, 150001, PR China.
J Ethnopharmacol. 2024 Mar 25;322:117657. doi: 10.1016/j.jep.2023.117657. Epub 2023 Dec 23.
Danlou tablet (DLT) is a traditional Chinese medicinal formulation known for replenishing Qi, promoting blood circulation, and resolving stasis. Its pharmacological actions primarily involve anti-inflammatory, antioxidant stress reduction, antiapoptotic, proangiogenic, and improved energy metabolism. DLT has been confirmed to have favorable therapeutic effects on ischemic stroke (IS). However, the underlying mechanism through which DLT affects IS-induced brain injury remains unknown.
This study aims to investigate the effects and underlying mechanisms of danlou tablet on ischemic stroke based on network pharmacology and experimental verification.
Using a transient middle cerebral artery occlusion (tMCAO) mouse model, the impact of DLT on the blood‒brain barrier (BBB) and brain injury in mice was assessed. Network pharmacology and bioinformatics analyses were utilized to explore the potential mechanisms of DLT in treating IS. Endothelial cells were cultured to observe the effects of DLT on vascular endothelial cells after oxygen-glucose deprivation/reperfusion, and these findings were validated in the brains of tMCAO mice.
DLT alleviated oxidative stress and brain damage in tMCAO mice, mitigating BBB damage. A total of 185 potential targets through which DLT regulates IS were identified, including COX2, a known critical marker of ferroptosis, which identified as a key target. In vitro and in vivo experiments demonstrated that DLT significantly (p < 0.05) improved cell death and vascular barrier damage in IS, reducing intracellular oxidative stress and COX2 protein levels while increasing SLC7A11 and GPX4 protein levels.
This study demonstrated that DLT maintained BBB integrity and alleviated brain injury of tMCAO mice by inhibiting ferroptosis. The study partially unraveled the mechanism through which DLT functioned in treating IS and further clarified the pivotal active components of DLT, thereby providing a theoretical scientific basis for treating IS with DLT.
丹鹿片(DLT)是一种传统的中药配方,具有补气、活血化瘀、祛瘀的功效。其药理作用主要包括抗炎、抗氧化应激、抗细胞凋亡、促血管生成和改善能量代谢。DLT 已被证实对缺血性脑卒中(IS)有良好的治疗作用。然而,DLT 影响 IS 诱导的脑损伤的潜在机制尚不清楚。
本研究旨在基于网络药理学和实验验证探讨丹鹿片对缺血性脑卒中的作用及其潜在机制。
采用短暂性大脑中动脉闭塞(tMCAO)小鼠模型,评估 DLT 对小鼠血脑屏障(BBB)和脑损伤的影响。利用网络药理学和生物信息学分析探讨 DLT 治疗 IS 的潜在机制。培养内皮细胞,观察 DLT 对氧葡萄糖剥夺/再灌注后血管内皮细胞的影响,并在 tMCAO 小鼠的大脑中进行验证。
DLT 减轻了 tMCAO 小鼠的氧化应激和脑损伤,减轻了 BBB 损伤。共鉴定出 185 个 DLT 调节 IS 的潜在靶点,包括 COX2,这是铁死亡的已知关键标志物,被鉴定为关键靶点。体内外实验表明,DLT 显著(p<0.05)改善了 IS 中的细胞死亡和血管屏障损伤,降低了细胞内氧化应激和 COX2 蛋白水平,同时增加了 SLC7A11 和 GPX4 蛋白水平。
本研究表明,DLT 通过抑制铁死亡来维持 tMCAO 小鼠 BBB 的完整性并减轻脑损伤。该研究部分揭示了 DLT 治疗 IS 的作用机制,并进一步阐明了 DLT 的关键活性成分,为 DLT 治疗 IS 提供了理论科学依据。